Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuta Katayama

Showing results (61-70 of 151) with videos related to

Pageof 16
Sort By:
Cytotherapy|April 19, 2024
Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time periodTakaaki Konuma, Kotaro Miyao, Hideki Nakasone, et al.
Plos One|November 16, 2013
Clinical significance of sIL-2R levels in B-cell lymphomasNoriaki Yoshida, Miyo Oda, Yoshiaki Kuroda, et al.
Bone Marrow Transplantation|July 31, 2021
Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation-a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCTYu Akahoshi, Yasuyuki Arai, Satoshi Nishiwaki, et al.
Annals of Hematology|March 15, 2023
Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical relatives in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia: a propensity score analysis of a nationwide databaseHidehiro Itonaga, Yasushi Miyazaki, Kazunari Aoki, et al.
Annals of Hematology|June 17, 2019
Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemiaMasamitsu Yanada, Jinichi Mori, Jun Aoki, et al.
Blood Advances|December 12, 2022
Novel risk assessment for the intensity of conditioning regimen in older patientsYu Akahoshi, Yuma Tada, Emiko Sakaida, et al.
Transplantation and Cellular Therapy|September 22, 2023
Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two DecadesMarie Ohbiki, Yuri Ito, Yoshihiro Inamoto, et al.
International Journal of Hematology|January 6, 2026
Prognostic factors influencing outcomes of allogeneic HCT for AML with monosomal karyotypeHiroki Yokoyama, Masamitsu Yanada, Shohei Mizuno, et al.
Blood Advances|March 20, 2020
Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantationSatoshi Kaito, Yujiro Nakajima, Konan Hara, et al.
Ejhaem|February 23, 2023
Outcomes after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients with der(1;7)(q10;p10)Hiroki Mizumaki, Ken Ishiyama, Jun Aoki, et al.
Pageof 16

Showing results (61-70 of 151) with videos related to

Sort By:
Pageof 16
Cytotherapy|April 19, 2024
Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time periodTakaaki Konuma, Kotaro Miyao, Hideki Nakasone, et al.
Plos One|November 16, 2013
Clinical significance of sIL-2R levels in B-cell lymphomasNoriaki Yoshida, Miyo Oda, Yoshiaki Kuroda, et al.
Bone Marrow Transplantation|July 31, 2021
Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation-a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCTYu Akahoshi, Yasuyuki Arai, Satoshi Nishiwaki, et al.
Annals of Hematology|March 15, 2023
Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical relatives in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia: a propensity score analysis of a nationwide databaseHidehiro Itonaga, Yasushi Miyazaki, Kazunari Aoki, et al.
Annals of Hematology|June 17, 2019
Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemiaMasamitsu Yanada, Jinichi Mori, Jun Aoki, et al.
Blood Advances|December 12, 2022
Novel risk assessment for the intensity of conditioning regimen in older patientsYu Akahoshi, Yuma Tada, Emiko Sakaida, et al.
Transplantation and Cellular Therapy|September 22, 2023
Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two DecadesMarie Ohbiki, Yuri Ito, Yoshihiro Inamoto, et al.
International Journal of Hematology|January 6, 2026
Prognostic factors influencing outcomes of allogeneic HCT for AML with monosomal karyotypeHiroki Yokoyama, Masamitsu Yanada, Shohei Mizuno, et al.
Blood Advances|March 20, 2020
Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantationSatoshi Kaito, Yujiro Nakajima, Konan Hara, et al.
Ejhaem|February 23, 2023
Outcomes after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients with der(1;7)(q10;p10)Hiroki Mizumaki, Ken Ishiyama, Jun Aoki, et al.
Pageof 16